Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Immediate-Release Alone In a 24-week placebo-controlled trial of sitagliptin 100 mg administered once daily added to a twice daily metformin immediate-release regimen, there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo
This does not mean the drugs are unsafe
These resources can transform your observations into actionable steps, helping you monitor everything from medication schedules to nutrition, side effects, and changes in your body
[3] Patients should report symptoms such as new shortness of breath, chest pain, syncope, or leg swelling immediately
40 In the FIGHT trial, long-term administration of liraglutide to HF and HFrEF patients with or without diabetes did not significantly improve LVEF after 24 weeks of treatment
US$ 23.69
US$ 29.97
US$ 27.80
